Celnor was launched to consolidate a highly fragmented TICC market across two areas. Life Sciences will provide testing and scientific services to customers active in the Biochemicals, Industrials and Pharmaceuticals industries. Environmental and Industrial Services will focus on testing, inspection and certification of assets, people and processes, such as testing for workplace safety.
The Inflexion difference
Inflexion has built up industry-leading expertise in consolidating the TICC market through a number of successful investments in the sector, including Phenna Group, Alcumus, BES Group and Cawood Scientific. This experience will allow Inflexion to build the business with an ambitious acquisition strategy.
We are delighted to be partnering with Inflexion, whose unrivalled expertise in our sector as well as proven buy-and-build experience make them the right investor as we create a business where entrepreneurial, founder-led companies can thrive. Their proactive yet thoughtful approach suits Celnor and allows us to move quickly when the right opportunity arises.
Simon Parrington, Chief Executive, Celnor